Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 207-215, May 2006

HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer

  • Antonio Rosato, M.D.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-49-8215800/8215858; fax: +39-49-8072854.
  • ,
  • Alessandra Banzato, M.S.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
  • ,
  • Gilda De Luca, M.S.

      Affiliations

    • Fidia Farmaceutici, Abano Terme, Italy
  • ,
  • Davide Renier, M.S.

      Affiliations

    • Fidia Farmaceutici, Abano Terme, Italy
  • ,
  • Fabio Bettella, Bc.Sc.

      Affiliations

    • Fidia Farmaceutici, Abano Terme, Italy
  • ,
  • Claudio Pagano, M.D.

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
  • ,
  • Giovanni Esposito, M.D.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
  • ,
  • Paola Zanovello, M.S.

      Affiliations

    • Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
  • ,
  • PierFrancesco Bassi, M.D.

      Affiliations

    • Department of Oncology and Surgical Sciences, Urology Section, University of Padova, Padova, Italy

Received 9 May 2005; received in revised form 3 August 2005; accepted 4 August 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by a grant from Fidia Farmaceutici spa. Antonio Rosato and Alessandra Banzato contributed equally to this work.

PII: S1078-1439(05)00219-X

doi:10.1016/j.urolonc.2005.08.020

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 207-215, May 2006